OOIR: Observatory of International Research

Papers

(The TQCC of Viruses-Basel is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays	593
Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution	449
COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention	332
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2	296
A Roadmap for Genome-Based Phage Taxonomy	283
VIRIDIC—A Novel Tool to Calculate the Intergenomic Similarities of Prokaryote-Infecting Viruses	267
Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms	247
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner	223
Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design	222
The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation	188
Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters	180
Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice	179
SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions	174
Comparison of Rapid Antigen Tests for COVID-19	162
Deploying Machine and Deep Learning Models for Efficient Data-Augmented Detection of COVID-19 Infections	149
Dengue: A Minireview	148
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?	145
Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection	134
Attitudes towards Anti-SARS-CoV2 Vaccination among Healthcare Workers: Results from a National Survey in Italy	129
Highly Pathogenic Avian Influenza Viruses at the Wild–Domestic Bird Interface in Europe: Future Directions for Research and Surveillance	128
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)	127
Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease	126
Mutations and Evolution of the SARS-CoV-2 Spike Protein	121
Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics?	119
Tracking SARS-CoV-2 in Sewage: Evidence of Changes in Virus Variant Predominance during COVID-19 Pandemic	118

Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2	117
Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19	117
SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production	111
Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro	110
Curcumin as an Antiviral Agent	110
Herpes zoster: A Review of Clinical Manifestations and Management	109
The Advantages and Challenges of Using Endolysins in a Clinical Setting	107
SARS-CoV-2 Infections and Viral Isolations among Serially Tested Cats and Dogs in Households with Infected Owners in Texas, USA	107
Silencing and Transcriptional Regulation of Endogenous Retroviruses: An Overview	105
Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-	105
Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications	102
Here, There, and Everywhere: The Wide Host Range and Geographic Distribution of Zoonotic Orthopoxviruses	101
A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies	99
Neutralizing Antibody Therapeutics for COVID-19	97
The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities	94
Propagation, Inactivation, and Safety Testing of SARS-CoV-2	94
The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner	92
Dance with the Devil: Stress Granules and Signaling in Antiviral Responses	90
The Spike of Concern—The Novel Variants of SARS-CoV-2	90
The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies	89
African Swine Fever in Wild Boar in Europe—A Review	86
A Comparison of Whole Genome Sequencing of SARS-CoV-2 Using Amplicon-Based Sequencing, Random Hexamers, and Bait Capture	85
Coronavirus Infections in Companion Animals: Virology, Epidemiology, Clinical and Pathologic Features	83
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues	82
Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature	82
Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak	82
SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations	82
Potential Antiviral Options against SARS-CoV-2 Infection	81
Liquid Biomolecular Condensates and Viral Lifecycles: Review and Perspectives	79
Lentiviral Vector Bioprocessing	79
The Mechanism behind Influenza Virus Cytokine Storm	77
Inactivation of Human Coronavirus by Titania Nanoparticle Coatings and UVC Radiation: Throwing Light on SARS-CoV-2	76
Aphid Transmission of Potyvirus: The Largest Plant-Infecting RNA Virus Genus	76
The Interplay between Adeno-Associated Virus and Its Helper Viruses	75
Antiviral Activity Exerted by Natural Products against Human Viruses	75
SARS-CoV-2, CT-Values, and Infectivity—Conclusions to Be Drawn from Side Observations	75
SARS-CoV-2 RNA Extraction Using Magnetic Beads for Rapid Large-Scale Testing by RT-qPCR and RT-LAMP	74
Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation	74
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188	74
Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals	74
SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light	74
Persistent Human Papillomavirus Infection	73
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2	73
Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2’-O-Methylation of Viral RNA	73
Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein	72
The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0–3.3 Days Can Be Explained by Immune Evasion	72
Mutation Rates, Mutation Frequencies, and Proofreading-Repair Activities in RNA Virus Genetics	68
Recombination in Coronaviruses, with a Focus on SARS-CoV-2	68
Viral Vectors for COVID-19 Vaccine Development	67
ASFV-G-∆I177L as an Effective Oral Nasal Vaccine against the Eurasia Strain of Africa Swine Fever	66

ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data	66
A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient	66
Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484Q	66
Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review	65
Regulation of KSHV Latency and Lytic Reactivation	65
Role of Viruses in the Pathogenesis of Multiple Sclerosis	65
The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-2	64
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence	64
Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week	64
Monkeypox: A Comprehensive Review	64
HIV-1 Maturation: Lessons Learned from Inhibitors	63
Anthropogenic Infection of Cats during the 2020 COVID-19 Pandemic	62
Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples	62
Host Immune Response Driving SARS-CoV-2 Evolution	62
SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron	62
Multifaceted Functions of CH25H and 25HC to Modulate the Lipid Metabolism, Immune Responses, and Broadly Antiviral Activities	62
Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse	61
Current Developments and Challenges in Plant Viral Diagnostics: A Systematic Review	61
SARS-CoV-2 Infections in Animals: Reservoirs for Reverse Zoonosis and Models for Study	61
Block-And-Lock: New Horizons for a Cure for HIV-1	60
Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India	60
LAMP-Coupled CRISPR–Cas12a Module for Rapid and Sensitive Detection of Plant DNA Viruses	60
Clinical Update of Severe Fever with Thrombocytopenia Syndrome	59
Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2	59
A Contemporary Systematic Review on Repartition of HPV-Positivity in Oropharyngeal Cancer Worldwide	59
The Lived Experience of Chronic Hepatitis B: A Broader View of Its Impacts and Why We Need a Cure	59
An Update of Orthopoxvirus Molecular Evolution	58
Current Trend in Antiviral Therapy for Chronic Hepatitis B	58
SARS-CoV-2 Disinfection of Air and Surface Contamination by TiO2 Photocatalyst-Mediated Damage to Viral Morphology, RNA, and Protein	57
Jumbo Phages: A Comparative Genomic Overview of Core Functions and Adaptions for Biological Conflicts	57
Synthetic Messenger RNA-Based Vaccines: From Scorn to Hype	57
Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval	57
SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants	56
Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies	56
SETDB1-Mediated Silencing of Retroelements	56
Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells	55
Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human Infection	55
Detection and Genome Sequencing of SARS-CoV-2 in a Domestic Cat with Respiratory Signs in Switzerland	55
SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland	55
World-Wide Prevalence and Genotype Distribution of Enteroviruses	54
The Fatty Acid Lipid Metabolism Nexus in COVID-19	54
Viral Infections and Systemic Lupus Erythematosus: New Players in an Old Story	54
Antiviral Bioactive Compounds of Mushrooms and Their Antiviral Mechanisms: A Review	54
The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV	54
Estimation of Serial Interval and Reproduction Number to Quantify the Transmissibility of SARS-CoV-2 Omicron Variant in South Korea	54
Monitoring Natural SARS-CoV-2 Infection in Lions (Panthera leo) at the Barcelona Zoo: Viral Dynamics and Host Responses	53
Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1	53
Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays	53
Disease Pandemics and Major Epidemics Arising from New Encounters between Indigenous Viruses and Introduced Crops	53
Extracellular Vesicles in the Pathogenesis of Viral Infections in Humans	53
Stability of African Swine Fever Virus in Carcasses of Domestic Pigs and Wild Boar Experimentally Infected with the ASFV “Estonia 2014” Isolate	52
In Vitro and In Vivo Models for Studying SARS-CoV-2, the Etiological Agent Responsible for COVID-19 Pandemic	52
Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds	52
Re-Emergence of Yellow Fever in Brazil during 2016–2019: Challenges, Lessons Learned, and Perspectives	52
Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19)	52
Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review	52
Dysregulated Interferon Response Underlying Severe COVID-19	52
Mechanism of Hepatitis B Virus cccDNA Formation	51
The Spillover of African Swine Fever in Western Poland Revealed Its Estimated Origin on the Basis of O174L, K145R, MGF 505-5R and IGR I73R/I329L Genomic Sequences	51
Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective	51
Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients	51
Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment	51
TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein	50
Modeling within-Host SARS-CoV-2 Infection Dynamics and Potential Treatments	50
RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients	50
Multiple Reassortants of H5N8 Clade 2.3.4.4b Highly Pathogenic Avian Influenza Viruses Detected in South Korea during the Winter of 2020–2021	50
Infection of Brain Organoids and 2D Cortical Neurons with SARS-CoV-2 Pseudovirus	50
Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target	50
Sialic Acid Receptors: The Key to Solving the Enigma of Zoonotic Virus Spillover	49
Detection of Highly Pathogenic Avian Influenza Virus H5N1 Clade 2.3.4.4b in Great Skuas: A Species of Conservation Concern in Great Britain	49
SARS-CoV-2 Reverse Zoonoses to Pumas and Lions, South Africa	49
HBV-Integration Studies in the Clinic: Role in the Natural History of Infection	49
Completion of the AAV Structural Atlas: Serotype Capsid Structures Reveals Clade-Specific Features	49
Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro	49
Detection of SARS-CoV-2 from Saliva as Compared to Nasopharyngeal Swabs in Outpatients	48
Viral Shrimp Diseases Listed by the OIE: A Review	48
Reporter Phage-Based Detection of Bacterial Pathogens: Design Guidelines and Recent Developments	48
Lentiviral Vectors for T Cell Engineering: Clinical Applications, Bioprocessing and Future Perspectives	48
Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives	48
HIV Protease: Historical Perspective and Current Research	48

SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus	47
Evaluation of the Safety Profile of the ASFV Vaccine Candidate ASFV-G-ΔI177L	47
Deletion of CD2-Like (CD2v) and C-Type Lectin-Like (EP153R) Genes from African Swine Fever Virus Georgia-∆9GL Abrogates Its Effectiveness as an Experimental Vaccine	47
A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development	47
Successful Treatment of Staphylococcus aureus Prosthetic Joint Infection with Bacteriophage Therapy	47
Identification and Tracking of Antiviral Drug Combinations	46
Review of Hepatitis E Virus in Rats: Evident Risk of Species Orthohepevirus C to Human Zoonotic Infection and Disease	46
Innate Immune Sensing of Influenza A Virus	46
Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy	46
The Main Molecular and Serological Methods for Diagnosing COVID-19: An Overview Based on the Literature	46
ViralRecall—A Flexible Command-Line Tool for the Detection of Giant Virus Signatures in ‘Omic Data	45
Viroplasms: Assembly and Functions of Rotavirus Replication Factories	45
Advances with RNAi-Based Therapy for Hepatitis B Virus Infection	45
APOBECs and Herpesviruses	45
Mosquito Vector Competence for Japanese Encephalitis Virus	45
A Putative Role of de-Mono-ADP-Ribosylation of STAT1 by the SARS-CoV-2 Nsp3 Protein in the Cytokine Storm Syndrome of COVID-19	45
Multiple Introductions Followed by Ongoing Community Spread of SARS-CoV-2 at One of the Largest Metropolitan Areas of Northeast Brazil	45
Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena	45
The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines	45
Intra-Host Diversity of SARS-Cov-2 Should Not Be Neglected: Case of the State of Victoria, Australia	45
Population Difference in Allele Frequency of HLA-C*05 and Its Correlation with COVID-19 Mortality	44
Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021–2022	44
Early Phase of the COVID-19 Outbreak in Hungary and Post-Lockdown Scenarios	44
The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis	44
Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air–Liquid Interface Cultured Human Primary Bronchial Epithelial Cells	44
SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity	44
Relationships between Viral Load and the Clinical Course of COVID-19	44
Nosocomial Outbreak of SARS-CoV-2 in a “Non-COVID-19” Hospital Ward: Virus Genome Sequencing as a Key Tool to Understand Cryptic Transmission	44
SARS-CoV-2 Subgenomic RNAs: Characterization, Utility, and Perspectives	44
Application of Oxford Nanopore Technology to Plant Virus Detection	43
Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy	43
A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy	43
Antiviral Drug Discovery for the Treatment of COVID-19 Infections	43
Persistent Detection and Infectious Potential of SARS-CoV-2 Virus in Clinical Specimens from COVID-19 Patients	43
Prognostic Values of Serum Ferritin and D-Dimer Trajectory in Patients with COVID-19	43
ViralFlow: A Versatile Automated Workflow for SARS-CoV-2 Genome Assembly, Lineage Assignment, Mutations and Intrahost Variant Detection	43
Lymphopenia Caused by Virus Infections and the Mechanisms Beyond	43
SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters	43
Human Cytomegalovirus and Autoimmune Diseases: Where Are We?	43
Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs	42
Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review	42
Structures and Functional Diversities of ASFV Proteins	42
The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus	42
Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies	42
Extracellular Vesicles in Viral Spread and Antiviral Response	42
miRNAs as Potential Biomarkers for Viral Hepatitis B and C	42
Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins	42
Nanotechnology as a Shield against COVID-19: Current Advancement and Limitations	41
Immunopathology of RSV: An Updated Review	41
Recent Progress in the Detection of Bacteria Using Bacteriophages: A Review	41
Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2	41
Illuminating the Plant Rhabdovirus Landscape through Metatranscriptomics Data	41
Recombinant ASF Live Attenuated Virus Strains as Experimental Vaccine Candidates	41
The Ecology of Nipah Virus in Bangladesh: A Nexus of Land-Use Change and Opportunistic Feeding Behavior in Bats	40
African Swine Fever Virus (ASFV): Biology, Genomics and Genotypes Circulating in Sub-Saharan Africa	40
Turmeric Root and Its Bioactive Ingredient Curcumin Effectively Neutralize SARS-CoV-2 In Vitro	40
Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic	40
SARS-CoV-2 and Placenta: New Insights and Perspectives	40
Xeno-Nucleic Acid (XNA) 2’-Fluoro-Arabino Nucleic Acid (FANA) Aptamers to the Receptor-Binding Domain of SARS-CoV-2 S Protein Block ACE2 Binding	40
Virome of a Feline Outbreak of Diarrhea and Vomiting Includes Bocaviruses and a Novel Chapparvovirus	40
Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations	40
Hepatitis B Virus-Associated Hepatocellular Carcinoma	40
Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interfero	39
Viral Membrane Fusion and the Transmembrane Domain	39
Analytical Sensitivity of Six SARS-CoV-2 Rapid Antigen Tests for Omicron versus Delta Variant	39
Hemagglutinin Stability and Its Impact on Influenza A Virus Infectivity, Pathogenicity, and Transmissibility in Avians, Mice, Swine, Seals, Ferrets, and Humans	39
Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression	39
The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic Applications	39
Prevention and Control Strategies of African Swine Fever and Progress on Pig Farm Repopulation in China	39
Deletion of the L7L-L11L Genes Attenuates ASFV and Induces Protection against Homologous Challenge	39
The Clinical Efficacy and Safety of Anti-Viral Agents for Non-Hospitalized Patients with COVID-19: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials	39
Hepatitis B Virus DNA is a Substrate for the cGAS/STING Pathway but is not Sensed in Infected Hepatocytes	39
Imbalanced Immune Response of T-Cell and B-Cell Subsets in Patients with Moderate and Severe COVID-19	39
Amantadine Inhibits SARS-CoV-2 In Vitro	39
Monkeypox, a Literature Review: What Is New and Where Does This concerning Virus Come From?	39
COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies	39
ACE2-Independent Alternative Receptors for SARS-CoV-2	39
Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?	38
Viral and Bacterial Co-Infections in the Lungs: Dangerous Liaisons	38
HIV-1 Entry and Membrane Fusion Inhibitors	38
HIV-1 Uncoating and Nuclear Import Precede the Completion of Reverse Transcription in Cell Lines and in Primary Macrophages	38
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients	38
Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19	38
Defining New Pathways to Manage the Ongoing Emergence of Bat Rabies in Latin America	38
Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2	38
Dengue Virus Infection: A Tale of Viral Exploitations and Host Responses	38
SARS-CoV-2: Evolution and Emergence of New Viral Variants	38
One Health Investigation of SARS-CoV-2 Infection and Seropositivity among Pets in Households with Confirmed Human COVID-19 Cases—Utah and Wisconsin, 2020	38
Re-Invasion of H5N8 High Pathogenicity Avian Influenza Virus Clade 2.3.4.4b in Hokkaido, Japan, 2020	38
SARS-like Coronaviruses in Horseshoe Bats (Rhinolophus spp.) in Russia, 2020	38
SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism	38
Vascular Inflammation Is Associated with Loss of Aquaporin 1 Expression on Endothelial Cells and Increased Fluid Leakage in SARS-CoV-2 Infected Golden Syrian Hamsters	38
Reproduction Number of the Omicron Variant Triples That of the Delta Variant	38
Porcine Epidemic Diarrhea Virus nsp15 Antagonizes Interferon Signaling by RNA Degradation of TBK1 and IRF3	37
A pre- and during Pandemic Survey of Sars-Cov-2 Infection in Stray Colony and Shelter Cats from a High Endemic Area of Northern Italy	37